Physicians Realty Trust (DOC) Scheduled to Post Quarterly Earnings on Wednesday

Share on StockTwits

Physicians Realty Trust (NYSE:DOC) will be posting its quarterly earnings results before the market opens on Wednesday, August 7th. Analysts expect Physicians Realty Trust to post earnings of $0.26 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Shares of DOC opened at $16.86 on Tuesday. The stock’s fifty day moving average price is $17.42. Physicians Realty Trust has a 12-month low of $15.18 and a 12-month high of $19.16. The company has a market capitalization of $3.12 billion, a PE ratio of 15.61 and a beta of 0.46. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.53 and a quick ratio of 1.53.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 18th. Investors of record on Wednesday, July 3rd were paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a yield of 5.46%. The ex-dividend date of this dividend was Tuesday, July 2nd. Physicians Realty Trust’s dividend payout ratio (DPR) is presently 85.19%.

Several equities analysts recently issued reports on the company. BMO Capital Markets cut Physicians Realty Trust from an “outperform” rating to a “market perform” rating and set a $17.45 price objective on the stock. in a research note on Tuesday, May 7th. Zacks Investment Research upgraded Physicians Realty Trust from a “sell” rating to a “buy” rating and set a $19.00 price objective on the stock in a research note on Wednesday, July 31st. Citigroup assumed coverage on Physicians Realty Trust in a research note on Thursday, June 20th. They issued a “neutral” rating and a $18.50 target price on the stock. ValuEngine cut Physicians Realty Trust from a “buy” rating to a “hold” rating in a research note on Thursday, June 27th. Finally, Capital One Financial cut Physicians Realty Trust from an “overweight” rating to an “equal weight” rating and set a $18.75 target price on the stock. in a research note on Thursday, May 2nd. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $18.27.

In other Physicians Realty Trust news, insider John T. Thomas sold 5,000 shares of the firm’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $18.26, for a total value of $91,300.00. Following the sale, the insider now directly owns 311,251 shares in the company, valued at $5,683,443.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John T. Thomas sold 3,700 shares of the firm’s stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $17.50, for a total value of $64,750.00. The disclosure for this sale can be found here. Insiders sold 15,000 shares of company stock worth $266,300 over the last quarter. 0.62% of the stock is currently owned by company insiders.

Physicians Realty Trust Company Profile

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.

Read More: What Are Cryptocurrencies?

Earnings History for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Avid Bioservices  Rating Increased to Hold at Zacks Investment Research
Avid Bioservices Rating Increased to Hold at Zacks Investment Research
CDK Global  Rating Lowered to Strong Sell at Zacks Investment Research
CDK Global Rating Lowered to Strong Sell at Zacks Investment Research
CNB Financial  Upgraded to “Buy” by BidaskClub
CNB Financial Upgraded to “Buy” by BidaskClub
Catasys  Downgraded to Sell at Zacks Investment Research
Catasys Downgraded to Sell at Zacks Investment Research
Stifel Nicolaus Begins Coverage on National Storage Affiliates Trust
Stifel Nicolaus Begins Coverage on National Storage Affiliates Trust
New Mountain Finance  Rating Lowered to Sell at Zacks Investment Research
New Mountain Finance Rating Lowered to Sell at Zacks Investment Research


© 2006-2019 Ticker Report